Share
Organ-on-Chips Market By Type (liver, heart, lungs and others); By Application (drug discovery, toxicology research and other applications); By end-user (Pharmaceutical and biotechnology companies, academic and research institutes and others) and Region -Analysis of Market Size, Share and Trends for 2014 - 2019 and Forecasts to 2030.
Organ-on-a-Chip Market to surpass USD 1271.6 million by 2031 from USD 68.3 million in 2021 at a CAGR of 38.50% in the forecasted period.
Organ-on-chips is a glass slide coated with human cells configured to imitate a tissue such as a lung or heart. It is also called a multi-channel 3D microfluid cell culture chip which develops a narrow channel for blood and airflow in organs. It is an artificial organ that replicates the activities, mechanics, and physiological responses of the organ system. It is the size of a AA battery that allows seeing the functionality of organs, their behavior, and response at the molecular and cellular levels.
Organ-on-a-Chip Market is expected to project a CAGR of 38.50% during the forecast period, 2021-2031
An increase in animal testing, research funding, capital investments, new product launches, and a rise in technological investments is likely to increase the growth of the market.
By organ type
it can be categorized into the liver, heart, lungs, and others. The liver segment shows significant growth due to the increased liver-related diseases along with the ability of on-chip hepatic tissues to maintain metabolism.
By application
it can be segmented into drug discovery, toxicology research, and other applications. Technological advancements and an increase in drug toxicity demand are reasons for the growth of the drug segment.
High usage is expected to increase the market size
The growing usage of the organ-on-chips market for animal testing and in the healthcare sector and a rising number of alliances between the pharmaceutical firms and chips manufacturers are expected to increase the market growth. Additionally, technological advancements and an increase in drug toxicity demand is also a driver in the market.
Technical issues and high costs will restrain the market growth
There are a lot of technical problems linked with organ-on-chip technology which acts as a restraint in the market along with the high cost as well as complexities in the organ-on-chip model. Restrictions in polydimethylsiloxane which is the most commonly used material for fabrications of the organ-on-chips market also act as a hindrance to the growth of the market.
North America holds the largest share in the organ-on-chips market due to the increased support of the government in drug discovery research activities as well as the presence of world-class research institutes and pharmaceutical and biotechnology industries in the region. Though, the APAC region is expected to become the fastest-growing region due to the increase in disposable income of the people and increased government funding for medicines in research institutes as well as the growing investments in research and development.
Business Strategy, Key Product offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis
Global Organ-on-Chips Market segments
The Organ-on-a-Chip Market size was estimated at USD 68.3 million in 2021 and is expected to reach USD 1271.6 million by 2030.
Nortis, Organovo Holdings, Inc., Hurel Corporation, Insphero AG, MIMETAS BV, Mimetas, Emulate, InSphero, Ascendance Bio, AxoSim
By organ type and By application segment are anticipated to hold the largest Food Service Equipment Market
Drivers: High usage is expected to increase the market size
Organ-on-chips is a glass slide coated with human cells configured to imitate a tissue such as a lung or heart. It is also called a multi-channel 3D microfluid cell culture chip which develops a narrow channel for blood and airflow in organs. It is an artificial organ that replicates the activities, mechanics, and physiological responses of the organ system.
Select License Type
Select License Type
FATPOS CLIENT Appriciation DURING THE PROJECT
Working with Fatpos Global, allowed us to take advantage of their knowledge and easy approach, allowing us to collect important data utilizing a variety of techniques. The results were clearly presented and explained, and FG responded to our questions with speed and expertise.
|
Swiss-based global building materials manufacturer |
The analyses and presentations Fatpos Global have produced for us have been of a very high caliber and have allowed us to proactively improve our customer relationship management. They have also done so while maintaining complete anonymity. Without any doubt, we suggest Fatpos Global to you.
|
|
Tech-powered construction company |
We appreciate the team’s punctuality, flexibility in terms of report modification, post report purchase support and pleasant reaction all around. Overall, my experience with this company was nothing but positive, and I couldn't be more grateful for their excellent service. Thank you for all that you do!
|
|
American global management consulting firm |
We are able to concentrate on the topics and implications that are most important to our clients thanks to the adaptability and responsiveness of the team at Fatpos Global. We would highly recommend this company to anyone in need of their services, and I will certainly be using them again in the future.
|
|
Headquartered in Zug, Switzerland, leading supplier of medical and surgical instrument |
To better study our client demographics, develop the ideal product-price architecture, and enhance our target marketing initiatives, we hired Fatpos Global. Every component of the project was completed, and we are very happy with the useful insights and actionable results.
|
|
Kosovan company, A leading organic fertilizers producer |
Thank you for your team's generous assistance, The final report was delivered to me, and I find it to be really helpful. Also, you may be sure that I will get in touch with you if I ever require fresh materials for market research. Gratitude once more.
|
|
German specialty chemicals company based in Cologne, Germany |
